The proportion of metastatic disease at diagnosis among NSCLC patients was numerically higher in the EZH2-low group, but this did not reach statistical significance (52.2% vs. 34.7%, p = 0.13).
← all excerpts
Prognostic impact of c-MYC and EZH2 expression in small cell and non-small cell lung carcinoma: a single-center retrospective study.
1
0.1300
0.1300